Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients-Reference-Cited by-同舟云学术

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients

Published:2019-05 Issue:2 Volume:153 Page:304-311
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Rodriguez-Freixinos V.,Lheureux S.,Mandilaras V.,Clarke B.,Dhani N.C.,Mackay H.,Butler M.O.,Wang L.,Siu L.L.,Kamel-Reid S.,Stockley T.,Bedard P.L.,Oza A.M.

Funder

Princess Margaret Cancer Foundation

Cancer Care Ontario

University of Toronto

Ontario Ministry of Health and Long-Term Care

SEOM

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference36 articles.

1. Rare cancers are not so rare: the rare cancer burden in Europe;Gatta;Eur. J. Cancer,2011

2. Clinical trial designs for rare diseases: studies developed and discussed by the international rare cancers initiative;Bogaerts;Eur. J. Cancer,2015

3. Diagnosis and treatment delay in gynecological malignancies. Does it affect outcome?;Menczer;Int. J. Gynecol. Cancer,2000

4. Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges;Ledermann;Am. Soc. Clin. Oncol. Educ. Book,2014

5. Next-generation sequencing: role in gynecologic cancers;Evans;J. Natl. Compr. Cancer Netw.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in precision therapy of low-grade serous ovarian cancer: A review;Medicine;2024-04-26

2. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma;Gynecologic Oncology;2023-02

3. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers;Current Oncology Reports;2022-03-26

4. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers;Gynecologic Oncology;2021-11

5. Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability;Cancer Research;2021-01-13